Clinical characteristics, hospital morbidity and mortality, and up to 1-year follow-up events of acute myocardial infarction patients: The first report from Iran

Coronary Artery Disease

Volumn 17, Issue 7, 2006, Pages 585-591

  Ghadimi, Hadi ^a   Bishehsari, Faraz ^a   Allameh, Farshad ^a   Bozorgi, Ali H ^a   Sodagari, Nassim ^a   Karami, Nazli ^a   Yaghoubi, Mahboubeh ^a   Emami, Sara ^a   Ghadimi, Fariba ^a   Haerizadeh, Bibi F ^a   Sanati, Archimedes ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Mortality; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; NITRATE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED; ANGIOPLASTY; CORONARY CARE UNITS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; IRAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 33750365109     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mca.0000224419.29186.97     Document Type: Article

References (41)

1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular disease. Part II. Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104:2855-2864.
2. World Health Organization. Prevention and control of cardiovascular disease. Alexandria, Egypt: Ala'din Alwan; 1995.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343:311-322.
4. Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997; 336:847-860.
5. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328:673-679.
6. Ounpuu S, Negassa A, Yusuf S. Inter-heart: a global study of risk factors for acute myocardial infarction. Am Heart J 2001; 141:711-721.
7. Ajdari A. Recent information regarding coronary heart disease. J Coron Heart Dis 1993; 3:555-556.
8. Daryani A, Berglund L, Andersson A, Kocturk T, Becker W, Vessby B. Risk factors for coronary heart disease among immigrant women from Iran and Turkey, compared to women of Swedish ethnicity. Ethn Dis 2005; 15:213-220.
9. Maleki M, Noohi F, Oraii S, Mohammad K, Eftekharzadeh M, Mirhaji P, et al. Prevalence of cardiovascular risk factors in Tehran: Healthy Heart Project. 11th Congress of Iranian Heart Association in Collaboration with Asian Pacific Society of Cardiology; October 1998, pp. 22-25.
10. Meraji S, Abuja PM, Hayn M, Kostner GM, Morris R, Oraii S, et al. Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. Atherosclerosis 2000; 150:403-412.
11. Sarraf-Zadegan N, Sayed Tabatabaei FA, Bashardoost N, Maleki A, Totonchi M, Habibi HR, et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol 1999; 54:257-263.
12. Zubaid M, Rashed WA, Husain M, Mohammad BA, Ridha M, Basharuthulla M, et al. A registry of acute myocardial infarction in Kuwait: patient characteristics and practice patterns. Can J Cardiol 2004; 20:783-787.
13. Jose VJ, Gupta SN. Mortality and morbidity of acute ST segment elevation myocardial infarction in the current era. Indian Heart J 2004; 56:210-214.
14. de Gevigney G, Ecochard R, Colin C, Rabilloud M, Excoffier S, Cao D, et al. Characteristics, management, and in-hospital mortality of acute myocardial infarction in the 'real world' in France: data from a large unselected cohort of 2,519 consecutive patients in a French region. Acta Cardiol 2000; 55:357-366.
15. Fox KA, Cokkinos DV, Deckers J, Keil J, Maggioni A, Steg G. The ENACT Study: a pan-European survey of acute coronary syndromes. Eur Heart J 2000; 21:1440-1449.
16. Steg PG, Goldberg RJ, Gore JM, Fox KAA, Eagle KA, Flather MD, et al. Baseline characteristics, management practices and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90:358-363.
17. Gheorghiade M, Ruzumna P, Borzak S, Havstad S, Ali A, Goldstein S. Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. Am Heart J 1996; 131: 250-256.
18. Furman MI, Dauerman HL, Goldberg RJ, Yarzbeski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 2001; 37:1571-1580.
19. Sawaya JI, Jazra C, Farhat F, Alam S, Eid EV, Sabra R. In-hospital mortality after acute myocardial infarction in Lebanon: incidence, associations, and influence of newer treatment regimens. J Med Liban 2000; 48:63-69.
20. Gottwik M, Zahn R, Schiele R, Schneider S, Gitt AK, Fraunberger L, et al. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1 + 2) Registries and the Myocardial Infarction Registry (MIR). Eur Heart J 2001; 22:1794-1801.
21. Mahon NG, O'Rorke C, Codd MB, McCann HA, McGarry K, Sugrue DD. Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart 1999; 81:478-482.
22. Di Chiaraa A, Chiarellab F, Savonittoc S, Lucci D, Bolognese L, De Servi S, et al. Epidemiology of acute myocardial infarction in the Italian CCU network. The BLITZ Study. Eur Heart J 2003; 24:1616-1629.
23. Samad Z, Rashid A, Khan MA, Mithani S, Khan MH, Khan MS, et al. Acute myocardial infarction: profile and management at a tertiary care hospital in Karachi. J Pak Med Assoc 2002; 52:45-50.
24. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110:588.
25. Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van de Werf F, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002; 359:189-198.
26. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345:494-502.
27. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879-1887.
28. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross JJ. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988; 62:1-7.
29. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction. Biology or methodology? JAMA 1990; 263:1092-1096.
30. Kambara H, Kinoshita M, Nakagawa M, Kawai C. Gender difference in long-term prognosis after myocardial infarction: clinical characteristics in 1000 patients. Jpn Circ J 1995; 59:1-10.
31. Robinson K, Conroy RM, Mulcahy R, Hickey N. Risk factors and in-hospital course of first episode of myocardial infarction or acute coronary insufficiency in women. J Am Coll Cardiol 1988; 11:932-936.
32. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. results from an international trial of 41 021 patients. Circulation 1995; 91:1659-1668.
33. Aufderheide TP. Arrhythmias associated with acute myocardial infarction and thrombolysis. Emerg Med Clin N Am 1998; 16:583-600.
34. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991; 325:1117-1122.
35. Puletti M, Zingales LD, Borgia C, Gatto F, Curione M, Matteoli S, et al. Neurological complications of the acute myocardial infarction. G Ital Cardiol 1981; 11:728-735.
36. Nakaoka T, Sada T, Kira Y, Okabe F, Sekine I, Tawara I, et al. Risk factors for the complication of cerebral infarction in Japanese patients with acute myocardial infarction. Jpn Heart J 1989; 30:635-643.
37. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002; 39:30-36.
38. AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet 1990; 335:427-431.
39. Yuksel H, Guzelsoy D, Yazicioglu N, Senocak M, Ozturk M, Demiroglu C. Long-term prognosis after a first myocardial infarction in Turkey: determinants of mortality and reinfarction. Cardiology 1994; 84:345-355.
40. Ohno J, Watanabe E, Toyama J, Kawamura T, Ohno M, Kodama I. Risk stratification and survival in post myocardial infarction patients: a large prospective and multicenter study in Japan. Int J Cardiol 2004; 93:263-268.
41. Lloyd-Jones DM, Camargo CA, Allen LA, Giugliano RP, O'Donnell CJ. Predictors of long-term mortality after hospitalization for primary unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol 2003; 92:1155-1159.